インフォメーション
Covid-19 Transmissibility and the binding inhibitors
2024-0420 Binding inhibitor 18 RNA medicine candidates for kidney disease patients.pdf (0.31MB)
2024-0326 Binding inhibitor16, Quick search for advanced medicines.pdf (0.19MB)
2024-0320 Binding inhibitor 15 Advanced medicines.pdf (0.28MB)
2024-0305 Binding inhibitos 14 AI and auto dock.pdf (0.33MB)
2024-0216 Binding inhibitors 12.pdf (0.36MB)
2024-0208 Binding inhibitors 11.pdf (0.4MB)
2024-0121 Binding inhibitors 10.pdf (0.48MB)
2024-0106 Binding inhibitos 9.pdf (0.44MB)
2023-1224 Bonding inhibitos 8.pdf (0.27MB)
2023-1222 Binding inhibitors 7.pdf (0.3MB)
2023-1122 Binding inhibitors 6.pdf (0.78MB)
2023-1103 Bonding inhibitors 5 Tea components.pdf (0.29MB)
2023-0916 Binding inhibitors 4.pdf (0.33MB)
2023-0825 Binding inhibitors 3.pdf (0.7MB)
2023-0815 Binding inhibitors 2.pdf (0.2MB)
2023-0808 Binding inhibitors.pdf (0.22MB)
Quantitative Analysis of Molecular Interactions from Chromatography Retention to Enzyme Selectivity
In silico analytical chemistry cover.pdf (2.07MB)
Prefase Aknowledgements Contents.pdf (0.36MB)
Chapter 1 Molecular Properties for in silico Analysis.pdf (1.22MB)
Chapter 2 Fundamental Molecular Interaction Mechanisms .pdf (4.42MB)
Chapter 3 Modeling Analysis Cf chromatographic Retention.pdf (5.15MB)
Chapter 4 Quantitative Explanation of Spectra.pdf (2.04MB)
Chapter 5 Preparation of Model Phases.pdf (4.47MB)
Chapter 6 Quantitative Explanation of Retention Mechanisms and Solvent Effects.pdf (2.64MB)
Chapter 7 Quantitative Analysis of the Retention in Liquid Chromatography.pdf (4.9MB)
Chapter 8 Enantiomer Recognition.pdf (4.32MB)
Chapter 9 Physical Biochemistry of Enzyme Reactions.pdf (5.48MB)
Index.pdf (0.16MB)